Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Applied Molecular Evolution to Present at JP Morgan H&Q 20th Annual Healthcare Conference.


Business Editors and Health/Medical Writers

BIOWIRE2K

SAN DIEGO--(BW HealthWire)--Jan. 9, 2002

Applied Molecular Evolution, Inc. (AME See AIT. ) (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: AMEV AMEV Armored Medical Evacuation Vehicle ), today announced that it will present at the JP Morgan Morgan, American family of financiers and philanthropists.

Junius Spencer Morgan, 1813–90, b. West Springfield, Mass., prospered at investment banking.
 H&Q 20th Annual Healthcare Conference on Thursday January 10th.

William D. Huse, M.D., Ph.D., President and Chief Executive Officer of AME will provide an update on the Company's recent events at 8:00 AM PT, Thursday, January 10th, 2002.

A live audio webcast of the presentation can be accessed at http://www.jpmhq.com.

Applied Molecular Evolution, Inc. is a leader in applying directed molecular evolution to improve healthcare by optimizing and developing human biotherapeutics. Directed molecular evolution is a process for optimizing genes and proteins for specific commercial purposes. Since its inception, AME's principal focus has been on applying its proprietary AMEsystem(TM) technology platform to human biotherapeutics, the largest market for directed molecular evolution. AME uses its proprietary technology to develop improved versions of currently marketed, FDA-approved biopharmaceuticals as well as novel human biotherapeutics.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements, including uncertainties related to product development, uncertainties related to the need for regulatory or other government approvals, dependence on proprietary technology, uncertainty of market acceptance of AME's products, uncertainties related to business opportunities, the receipt of future payments, including royalties, the continuation of customer relationships and other risks cited in AME's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2000, and other SEC filings. These forward-looking statements speak only as of the date hereof here·of  
adv.
Of this.


hereof
Adverb

Formal or law of or concerning this

Adv. 1. hereof - of or concerning this; "the twigs hereof are physic"
. AME disclaims any intent or obligation to update these forward- looking statements.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 9, 2002
Words:288
Previous Article:Standard Automotive Corporation Announces Subsidiary's Sale of Assets.
Next Article:ACNielsen Media International Names Hadfield to Head North American Operations.



Related Articles
Largest Investment Banking Healthcare Conference to Open Jan. 8 in San Francisco.
REPEAT/Largest Investment Banking Healthcare Conference to Open Jan. 8 in San Francisco.
Dyax to Present Company Update At the JP Morgan Chase H&Q 20th Annual Healthcare Conference.
Pharsight Executives to Present at JP Morgan H&Q Healthcare and Needham Growth Conferences on January 10, 2002.
Applied Molecular Evolution to Present at CIBC World Markets Healthcare Conference; Presentation Available via Webcast.
Applied Molecular Evolution to Present at SG Cowen Global Healthcare Conference; Presentation to be Webcast.
Applied Molecular Evolution Advances Optimized Versions of anti-TNF alpha and anti-CD20 Monoclonal Antibody Therapeutic Candidates.
Applied Molecular Evolution to Webcast Presentation Thursday January 9th from JP Morgan HQ Healthcare Conference.
Applied Molecular Evolution, Inc. to Present at 23rd Annual SG Cowen Healthcare Conference.
Applied Molecular Evolution to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference on May 1.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles